2016 Annual Conference on Retroviruses and Opportunistic Infections

The following were presentations/posters originating from HNRP research presented at the 2016 Annual Conference on Retroviruses and Opportunistic Infections taking place in Boston, Massachusetts from 2/22/16 – 2/25/16: 

de Oliveria MF, Chaillon A, Letendre S, Strain M, Ellis R, Morris S, Little S, Smith DM, Gianella S. (2016). Compartmentalized HIV DNA populations persist in CSF despite suppressive ART.

Evering T, St. Bernard L, Abolade J, Mohri H, Markowitz M. (2016). Relative frequency of drug resistance mutations on individual HIV-1 genomes in HAND. 

Hinckley S, Sherman S, Brookie M, Momper J, Ma Q, Letendre S, Ellis R, Bang A. (2016). Neurotoxicity screening of antiretroviral drugs with human iPSC-derived neurons.

Hoenigl M, de Oliveira MF, Pérez Santiago J, Finkelman M, Zhang Y, Morris S, Ellis RJ, Gianella S (1→3)-β-D-Glucan levels correlate with neurocognitive functioning in HIV infection.

Kallianpur A, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan J, Bush W, Heaton R, Samuels D, Franklin D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Grant I, Simpson D, Hulgan T, for the CHARTER Group. (2016). Novel CSF biomarker associations with HIV-associated neurocognitive disorder (HAND).

Anderson A, Iudicello J, Kallianpur A, Tolentino K, Ellis R, Grant I, Hulgan T, Letendre S. (2016). CNS drug distribution and CSF inflammation during suppressive antiretroviral therapy.

Ma Q, Iudicello J,  Liu X, Franklin D. (2016). CYP2B6 genotype affects global neurocognitive impairment in HIV-positive patients receiving Efavirenz: A CHARTER and China neuroAIDS study.

Samuels D, Kallianpur A, Guo Y, Brown T, Mehta S, Ellis R, Letendre S, Hulgan T, for the CHARTER study group. (2016). Mitochondrial DNA copy number and neurocognitive impairment in HIV-infected persons.

Click Here to view abstract text and/or posters if available.  The ordering is alphabetically by title by year.